EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Primary Tumor Epigenetic and Transcriptomic Alterations Associated with Nodal Burden and Metastatic Risk in ER+/HER2− Breast Cancer

Sandra Iñiguez-Muñoz, Andrés F Bedoya-López iD, Miquel Ensenyat-Mendez iD, Pere Llinàs-Arias iD, Sookyung Ahn iD, Rachel E Factor, Diego M Marzese iD, Maggie L DiNome iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27177901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Sandra Iñiguez-Muñoz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Epigenesis, Genetic, Receptors, Estrogen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Govern de les Illes Balears, NCI NIH HHS, CEP/EDUIB-Santander.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

De-escalation of axillary surgery has resulted in the loss of pathologic nodal information, yet the extent of lymph node involvement remains an important determinant of treatment decisions in estrogen receptor-positive (ER+)/HER2− disease. We examined whether primary tumors differed molecularly according to the extent of this regional dissemination. Genome-wide DNA methylation profiling of primary ER+/HER2− tumors from 47 patients with pN1 (n = 29) vs. >pN1 (n = 18) disease showed differences concentrated at promoters of developmental and cell-adhesion genes. By integrating methylomes with transcriptomes from the TCGA-BRCA cohort (n = 148) and clinical outcomes from KM Plotter (RFS, n = 1154; OS, n = 442; DMFS, n = 423), we identified four genes (ARL10, RIC3, CXCL14, KCNH2) showing concordant molecular and clinical associations, from which we derived the Lymph-node Involvement Outcome Numerator (LION) score. Lower LION scores were observed in metastatic lesions from the AURORA US cohort (n = 45). In SCAN-B (n = 3969), lower scores were associated with shorter distant recurrence-free intervals (HR = 0.38; 95% CI 0.23–0.62); this association persisted after adjustment for age, nodal and tumor category but was lost after adjustment for histological grade (HR = 0.83; 95% CI 0.48–1.44), indicating that the score and grade capture overlapping biology. These findings suggest that primary tumors already display coordinated epigenetic and transcriptional alterations associated with the extent of metastatic dissemination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesEpigenesis, GeneticReceptors, EstrogenTranscriptomeHumansFemaleDNA MethylationLymphatic MetastasisGene Expression Regulation, NeoplasticMiddle Aged

Stichwörter der Autor:innen

DNA methylationER+/HER2−breast cancerepigeneticslymph node metastasisnodal burden

Substanzen

Erb-b2 Receptor Tyrosine KinasesReceptors, EstrogenERBB2 protein, human

Autor:innen und Institutionen

  • Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA.
  • Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
  • Department of Surgery, Kangnam Sacred Heart Hospital, Hallym University, Seoul 07441, Republic of Korea.
  • Department of Pathology, Duke University, Durham, NC 27710, USA.
  • Duke Cancer Institute, Durham, NC 27710, USA.

ORCID-Profile: Andrés F Bedoya-López, Miquel Ensenyat-Mendez, Pere Llinàs-Arias, Sookyung Ahn, Diego M Marzese, Maggie L DiNome

Förderung

  • Govern de les Illes Balears
  • NCI NIH HHS
  • CEP/EDUIB-Santander
  • United States Department of Defense
  • Spanish Association Against Cancer
  • Department of Defense Breast Cancer Research Program
  • Duke University BioRepository & Precision Pathology Center
  • National Cancer Institute

Zitieren

APA

Iñiguez-Muñoz, S., Bedoya-López, A. F., Ensenyat-Mendez, M., Llinàs-Arias, P., Ahn, S., Factor, R. E., Marzese, D. M., & DiNome, M. L. (2026). Primary Tumor Epigenetic and Transcriptomic Alterations Associated with Nodal Burden and Metastatic Risk in ER+/HER2− Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177901

Vancouver

Iñiguez-Muñoz S, Bedoya-López AF, Ensenyat-Mendez M, Llinàs-Arias P, Ahn S, Factor RE, et al. Primary Tumor Epigenetic and Transcriptomic Alterations Associated with Nodal Burden and Metastatic Risk in ER+/HER2− Breast Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177901

BibTeX
@article{IiguezMuoz2026,
  author = {Iñiguez-Muñoz, Sandra and Bedoya-López, Andrés F and Ensenyat-Mendez, Miquel and Llinàs-Arias, Pere and Ahn, Sookyung and Factor, Rachel E and Marzese, Diego M and DiNome, Maggie L},
  title = {Primary Tumor Epigenetic and Transcriptomic Alterations Associated with Nodal Burden and Metastatic Risk in ER+/HER2− Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27177901}
}
Kostenlos starten →